← back to search

Kelly Walkovich

University of Michigan–Ann Arbor · US
Area of research
Immunology · Genetics
Research interest
Research interests include Medicine, Internal medicine, Aplastic anemia, Hemophagocytic lymphohistiocytosis, Pediatrics, and Germline.
h-index
citations
1,504
works
15
NIH funding
primary concept
email

Recent publications

Eltrombopag in combination with immunosuppressive therapy in pediatric severe aplastic anemia: phase 2 ESCALATE trial
Blood Advances 2025cited by 6position: middledoi
Emapalumab use in malignancy-associated hemophagocytic lymphohistiocytosis in the United States: the REAL-HLH study
Blood Advances 2025cited by 1position: middledoi
Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab
Blood Advances 2024cited by 29position: middledoi
Emapalumab Treatment in Patients With Rheumatologic Disease–Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study
Arthritis & Rheumatology 2024cited by 16position: middledoi
Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis
British Journal of Haematology 2024cited by 14position: middledoi
Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome
Journal of Allergy and Clinical Immunology 2022cited by 119position: middledoi
Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome
Nature Communications 2021cited by 172position: middledoi
Histiocytic Neoplasms, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2021cited by 74position: middledoi
Multidisciplinary Guidance Regarding the Use of Immunomodulatory Therapies for Acute Coronavirus Disease 2019 in Pediatric Patients
Journal of the Pediatric Infectious Diseases Society 2020cited by 55position: middledoi
Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study
The Lancet Haematology 2019cited by 114position: middledoi
Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study
Haematologica 2019cited by 66position: middledoi
Leucine for the Treatment of Transfusion Dependence in Patients with Diamond Blackfan Anemia
Blood 2018cited by 2position: middledoi
Somatic mutations and clonal hematopoiesis in congenital neutropenia
Blood 2017cited by 121position: middledoi
Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United States
JAMA 2014cited by 670position: middledoi
Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): An initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC)
Pediatric Blood & Cancer 2013cited by 45position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Adrianna Vlachos · Northwell Health4 papers (2013–2025)Alison A. Bertuch · Baylor College of Medicine3 papers (2013–2025)Edward M. Behrens · Children's Hospital of Philadelphia3 papers (2020–2025)Shanmuganathan Chandrakasan · Emory University3 papers (2020–2025)Akiko Shimamura · Harvard University3 papers (2013–2025)Michael B. Jordan · Universidad Cervantina2 papers (2024–2025)Zora R. Rogers · Southwestern Medical Center2 papers (2013–2018)Blachy J. Dávila Saldaña · National Hospital2 papers (2024–2025)Jason E. Farrar · National Human Genome Research Institute2 papers (2018–2025)David A. Williams · Harvard University2 papers (2013–2025) · 2 papers (2013–2018) · 2 papers (2013–2025)Anish Ray · University of North Texas2 papers (2024–2025)Carolyn M. Bennett · Emory University2 papers (2013–2025)Jennifer W. Leiding · Nationwide Children's Hospital2 papers (2024–2025)Arun Panigrahi · University of California Davis Medical Center2 papers (2018–2025) · 2 papers (2024–2025)Michelle L. Hermiston · VinUniversity2 papers (2024–2025)Carl E. Allen · Baylor College of Medicine2 papers (2024–2025)Abiola Oladapo · The University of Texas at Austin2 papers (2024–2025)